VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
-10.63%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$349M
AUM Growth
+$349M
(-12%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Assembly Biosciences
ASMB
|
$1.49M |
| 2 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$218K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $65.7M | 18.81% |
3,931,818
| – | – |
|
|
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $63.2M | 18.11% |
2,747,433
| – | – |
|
|
KRON
3
DELISTED
Kronos Bio
KRON
| $58M | 16.6% |
2,765,314
| – | – |
|
4
Praxis Precision Medicines
PRAX
$958M
| $54.3M | 15.57% |
2,939,329
| – | – |
|
5
Dyne Therapeutics
DYN
$1.92B
| $48.1M | 13.77% |
2,960,046
| – | – |
|
6
Allogene Therapeutics
ALLO
$251M
| $46.2M | 13.24% |
1,798,163
| – | – |
|
|
OYST
7
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $7.59M | 2.17% |
640,070
-18,398
| -3% | -$218K |
|
8
Q32 Bio
QTTB
$20.9M
| $6.07M | 1.74% |
770,845
| – | – |
|
|
9
Assembly Biosciences
ASMB
$190M
| – | – |
-384,635
| Closed | -$1.49M |
|